MedicaidAdministrativeMedium impact
Changes to fee-for-service Avastin (bevacizumab) billing for eye clinics, effective June 23, 2020
Oregon Health Plan·OR · Ophthalmology·Provider
Effective date
Jun 23, 2020
We identified it
Jun 20, 2026
Summary
Oregon Health Plan has implemented changes to fee-for-service billing procedures for Avastin (bevacizumab) injections specifically for eye clinics. This affects how ophthalmology practices in Oregon bill for this medication under Medicaid fee-for-service arrangements.
Action Required
Oregon eye clinic billing teams should review the complete policy document at the provided URL to understand specific billing procedure changes for Avastin injections under Oregon Health Plan fee-for-service. Update billing workflows and staff training accordingly for Medicaid patients receiving bevacizumab treatments.